TY - JOUR
T1 - Perinatal outcomes of pregnancies resulting from assisted reproduction technology in SARS-CoV-2-infected women
T2 - a prospective observational study
AU - Engels Calvo, Virginia
AU - Cruz Melguizo, Sara
AU - Abascal-Saiz, Alejandra
AU - Forcén Acebal, Laura
AU - Sánchez-Migallón, Amalia
AU - Pintado Recarte, Pilar
AU - Cuenca Marín, Celia
AU - Marcos Puig, Beatriz
AU - Del Barrio Fernández, Pablo G.
AU - Nieto Velasco, Olga
AU - de la Cruz Conty, María Luisa
AU - Martínez-Perez, Oscar
AU - Garrido Luque, María Belén
AU - Fernández, Camino Fernández
AU - Yarza, Ana Villalba
AU - Canedo Carballeira, Esther María
AU - Dueñas Carazo, María Begoña
AU - Aguilar, Rosario Redondo
AU - Sánchez-Vegazo García, Ángeles
AU - Silvares, Esther Álvarez
AU - Pardo Pumar, María Isabel
AU - Álvarez-Mallo, Macarena Alférez
AU - Carmona, Víctor Muñoz
AU - Pérez, Noelia Pérez
AU - Colomo, Cristina Álvarez
AU - Mateu, Onofre Alomar
AU - Di Leo, Claudio Marañon
AU - Millán, María del Carmen Parada
AU - García, Adrián Martín
AU - Martínez, José Navarrina
AU - Fornell, Anna Mundó
AU - Salvador, Elena Pascual
AU - Gómez, Tania Manrique
AU - Meca Casbas, Marta Ruth
AU - Grimalt, Noemí Freixas
AU - Aquise, Adriana
AU - Gil, María del Mar
AU - Amorós, Eduardo Cazorla
AU - Sánchez, Alberto Armijo
AU - Conca Rodero, María Isabel
AU - Oreja Cuesta, Ana Belén
AU - Aguilar, Cristina Ruiz
AU - García, Susana Fernández
AU - Gómez, Mercedes Ramírez
AU - Aguilar Galán, Esther Vanessa
AU - Pérez, Rocío López
AU - Luque, Carmen Baena
AU - Jiménez Losa, Luz María
AU - Pérez, Susana Soldevilla
AU - Granell Escobar, María Reyes
N1 - Publisher Copyright:
© 2021 American Society for Reproductive Medicine
PY - 2021/9
Y1 - 2021/9
N2 - Objective: To evaluate the perinatal and maternal outcomes of pregnancies in women infected with SARS-CoV-2, comparing spontaneous and in vitro fertilization (IVF) pregnancies (with either own or donor oocytes). Design: Multicenter, prospective, observational study. Setting: 78 centers participating in the Spanish COVID19 Registry. Patient(s): 1,347 pregnant women with SARS-CoV-2 positive results registered consecutively between February 26 and November 5, 2020. Intervention(s): The patients’ information was collected from their medical records, and multivariable regression analyses were performed, controlling for maternal age and the clinical presentation of the infection. Main Outcome Measure(s): Obstetrics and neonatal outcomes, pregnancy comorbidities, intensive care unit admission, mechanical ventilation need, and medical conditions. Result(s): The IVF group included 74 (5.5%) women whereas the spontaneous pregnancy group included 1,275 (94.5%) women. The operative delivery rate was high in all patients, especially in the IVF group, where cesarean section became the most frequent method of delivery (55.4%, compared with 26.1% of the spontaneous pregnancy group). The reason for cesarean section was induction failure in 56.1% of the IVF patients. IVF women had more gestational hypertensive disorders (16.2% vs. 4.5% among spontaneous pregnancy women, adjusted odds ratio [aOR] 5.31, 95% confidence interval [CI] 2.45–10.93) irrespective of oocyte origin. The higher rate of intensive care unit admittance observed in the IVF group (8.1% vs. 2.4% in the spontaneous pregnancy group) was attributed to preeclampsia (aOR 11.82, 95% CI 5.25–25.87), not to the type of conception. Conclusion(s): A high rate of operative delivery was observed in pregnant women infected with SARS-CoV-2, especially in those with IVF pregnancies; method of conception did not affect fetal or maternal outcomes, except for preeclampsia. Clinical Trial Registration Number: NCT04558996.
AB - Objective: To evaluate the perinatal and maternal outcomes of pregnancies in women infected with SARS-CoV-2, comparing spontaneous and in vitro fertilization (IVF) pregnancies (with either own or donor oocytes). Design: Multicenter, prospective, observational study. Setting: 78 centers participating in the Spanish COVID19 Registry. Patient(s): 1,347 pregnant women with SARS-CoV-2 positive results registered consecutively between February 26 and November 5, 2020. Intervention(s): The patients’ information was collected from their medical records, and multivariable regression analyses were performed, controlling for maternal age and the clinical presentation of the infection. Main Outcome Measure(s): Obstetrics and neonatal outcomes, pregnancy comorbidities, intensive care unit admission, mechanical ventilation need, and medical conditions. Result(s): The IVF group included 74 (5.5%) women whereas the spontaneous pregnancy group included 1,275 (94.5%) women. The operative delivery rate was high in all patients, especially in the IVF group, where cesarean section became the most frequent method of delivery (55.4%, compared with 26.1% of the spontaneous pregnancy group). The reason for cesarean section was induction failure in 56.1% of the IVF patients. IVF women had more gestational hypertensive disorders (16.2% vs. 4.5% among spontaneous pregnancy women, adjusted odds ratio [aOR] 5.31, 95% confidence interval [CI] 2.45–10.93) irrespective of oocyte origin. The higher rate of intensive care unit admittance observed in the IVF group (8.1% vs. 2.4% in the spontaneous pregnancy group) was attributed to preeclampsia (aOR 11.82, 95% CI 5.25–25.87), not to the type of conception. Conclusion(s): A high rate of operative delivery was observed in pregnant women infected with SARS-CoV-2, especially in those with IVF pregnancies; method of conception did not affect fetal or maternal outcomes, except for preeclampsia. Clinical Trial Registration Number: NCT04558996.
KW - COVID-19
KW - assisted reproduction
KW - cohort study
KW - intensive care unit
KW - pregnancy
UR - http://www.scopus.com/inward/record.url?scp=85105440708&partnerID=8YFLogxK
U2 - 10.1016/j.fertnstert.2021.04.005
DO - 10.1016/j.fertnstert.2021.04.005
M3 - Article
C2 - 33972083
AN - SCOPUS:85105440708
SN - 0015-0282
VL - 116
SP - 731
EP - 740
JO - Fertility and Sterility
JF - Fertility and Sterility
IS - 3
ER -